This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
bacteria:t3e:xopj1 [2020/09/21 15:23] – fboernke | bacteria:t3e:xopj1 [2025/02/13 11:38] (current) – jfpothier | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== XopJ1 ====== | + | ====== |
Author: [[https:// | Author: [[https:// | ||
Internal reviewer: [[https:// | Internal reviewer: [[https:// | ||
- | Expert reviewer: Frederik Börnke | + | Expert reviewer: |
Class: XopJ\\ | Class: XopJ\\ | ||
Family: XopJ1\\ | Family: XopJ1\\ | ||
Prototype: XCV2156 (// | Prototype: XCV2156 (// | ||
- | RefSeq | + | GenBank |
+ | RefSeq ID: [[https:// | ||
3D structure: Unknown | 3D structure: Unknown | ||
Line 15: | Line 16: | ||
=== How discovered? === | === How discovered? === | ||
- | XopJ was initially discovered as a HrpG-induced gene in a cDNA-AFLP screen in // | + | XopJ was initially discovered as a HrpG-induced gene in a cDNA-AFLP screen in // |
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
Line 65: | Line 66: | ||
White F, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // | White F, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // | ||
+ | |||
+ | ===== Acknowledgements ===== | ||
+ | |||
+ | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation in Science and Technology). | ||